Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-013719
Filing Date
2024-12-13
Accepted
2024-12-13 09:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28981
2 filename2.txt TEXT-EXTRACT 2230
  Complete submission text file 0000000000-24-013719.txt   42903
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filed for) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 377-07295
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)